Skip to main content
Home
Toggle menu

Give Now

  • For Patients
  • School Of Medicine
  • About
    • Leadership
    • Department Directory
    • News
    • Events
    • Annual Report
    • Nashville
  • Divisions
    • Allergy, Pulmonary and Critical Care Medicine
    • Cardiovascular Medicine
    • Diabetes, Endocrinology and Metabolism
    • Epidemiology
    • Gastroenterology, Hepatology and Nutrition
    • General Internal Medicine and Public Health
    • Genetic Medicine and Clinical Pharmacology
    • Geriatric Medicine
    • Hematology and Oncology
    • Infectious Diseases
    • Nephrology and Hypertension
    • Rheumatology and Immunology
  • Education
    • Overview
    • Internal Medicine Residency Program
    • Physician-Scientist Training Program
    • Internal Medicine-Pediatrics Residency Program
    • Fellowship Programs
    • EXCellence In TEaching Pathway
    • Physician-Scientist Doctoral Program
    • Medical Students
    • Alumni
    • Medicine Grand Rounds
  • Research
    • Overview
    • Clinical Trials
    • Publications
    • Research Centers and Labs
  • Faculty
    • Open Faculty Positions
    • Professional Development
  • Clinical Initiatives
    • Digital Health
    • Physician Builder Program

User Detail

Spyros Kalams, MD

Professor of Medicine

Division of Infectious Diseases
Spyros Kalams
Professional Bio
Spyros Kalams, MD, is a Professor of Medicine in the Division of Infectious Diseases, Department of Medicine at Vanderbilt University Medical Center. He is the Director of the Laboratory Sciences Core of the Tennessee Center for AIDS Research and he is the Principal investigator of the Vanderbilt HIV Vaccine Trials Clinical Research Site (VV-CRS), which tests candidate HIV vaccines in phase 1-3 trials. The VV-CRS is now part of the Coronavirus Vaccine Prevention Network and performs clinical trials of SARS CoV-2 vaccine candidates. The Kalams laboratory studies cellular immune responses to intracellular pathogens such as viruses and mycobacteria, and vaccines for influenza, HIV, and SARS CoV-2. Current active projects include 1) Determining the correlates of immune control of latent tuberculosis infection by longitudinally studying a cohort of individuals in Brazil 2) Understanding T and B cell populations that predict the ability of immune compromised individuals to respond to influenza vaccination in large clinical trials. Current trials under evaluation include pediatric stem cell, adult stem cell, adult solid organ transplant (non-lung), and adult lung transplant recipients. 3) Characterization of cellular immune responses to HIV infection and to HIV vaccines 4) Evaluation of cellular immune responses to SARS CoV-2 infection and vaccines and 5) Determining why adults have diminishing influenza vaccine responses with age. His laboratory uses bioinformatics techniques to analyze T and B cell phenotypes by fluorescence and mass cytometry, the transcriptomic profile, and T cell receptor usage of pathogen and vaccine responses at the single cell level.
Relevant Links
Provider Profile
Publications
View Publications

Education

MD - University of Connecticut, 1987

Residency - Beth Israel Deaconess Medical Center, 1990

Fellowship - Infectious Diseases - Massachusetts General Hospital, 1994

Contact

Email 
Kimryn.Rathmell@Vumc.Org 
Address 
777 Preston Research Building 
2220 Pierce Ave 
Nashville, TN 37232-6307

Submitted by admin on Thu, 06/01/2023 - 04:28

1161 21st Ave S
Nashville, TN 37232

(615) 322-5000

Quick Links

  • Home
  • About
  • Divisions
  • Education
  • Research
  • Faculty
  • Intranet

Support Our Work

Start a fundraiser or donate to the Department of Medicine.

Give Now

Vanderbilt Health is committed to fostering an environment where everyone has the chance to thrive and is committed to the principles of equal opportunity. EOE/Vets/Disabled.

Copyright © Vanderbilt University Medical Center

sfy39587stp18